|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 136,300.00 KRW | -1.94% |
|
+9.21% | +28.95% |
| 05-27 | HEALTH ROUNDS-Veracyte genomic test identifies breast cancer patients who can skip chemo | RE |
| 05-15 | ORION Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 5,388B 3.52B 3.08B 2.83B 2.64B 5B 335B 5.08B 33.95B 13.2B 165B 13.21B 12.93B 568B | P/E 2026 * |
11.2x | P/E 2027 * | 10.3x |
|---|---|---|---|---|---|
| Enterprise Value | 3.92B 2.56M 2.24M 2.06M 1.92M 3.64M 244M 3.7M 24.73M 9.61M 120M 9.62M 9.42M 413M | EV / Sales 2026 * |
1.06x | EV / Sales 2027 * | 0.93x |
| Free-Float |
56.16% | Yield 2026 * |
2.9% | Yield 2027 * | 3.06% |
| 1 day | -1.94% | ||
| 1 week | +9.21% | ||
| Current month | +3.34% | ||
| 1 month | +6.15% | ||
| 3 months | +4.85% | ||
| 6 months | +32.20% | ||
| Current year | +28.95% |
| 1 week | 126,200 | 145,300 | |
| 1 month | 120,300 | 145,300 | |
| Current year | 102,000 | 150,100 | |
| 1 year | 99,000 | 150,100 | |
| 3 years | 81,800 | 150,100 | |
| 5 years | 80,200 | 150,100 | |
| 10 years | 75,700 | 164,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Seung-Joon Lee
CEO | Chief Executive Officer | 66 | 31/12/2021 |
Cheol-Gon Tam
PRN | Corporate Officer/Principal | 71 | 01/04/1980 |
| Director | Title | Age | Since |
|---|---|---|---|
In-Cheol Heo
BRD | Director/Board Member | 66 | 30/06/2014 |
Wook Lee
BRD | Director/Board Member | 67 | 29/02/2020 |
Seung-Joon Lee
CHM | Chairman | 66 | 31/12/1993 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/01/25 | Others | 17 | 0.0000% | |||
| 19/05/24 | Free | 5,758,550 | 14.5653% | |||
| 19/05/24 | Others | 2,065 | 0.0052% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.94% | +9.21% | +15.02% | +13.58% | 3.57B | ||
| +0.12% | +1.51% | +6.23% | -21.60% | 271B | ||
| +0.14% | -0.47% | -12.44% | -16.49% | 78.19B | ||
| -0.76% | +1.77% | +6.35% | +30.14% | 54.19B | ||
| -0.46% | +0.33% | +37.37% | +1.63% | 37.01B | ||
| +2.07% | +7.40% | +57.48% | +115.48% | 35.89B | ||
| -3.07% | +3.09% | +2.86% | -27.06% | 36.95B | ||
| -3.13% | +8.10% | -6.25% | -28.54% | 30.08B | ||
| +0.91% | +4.02% | +22.22% | +27.55% | 29.29B | ||
| +0.32% | -4.56% | +30.80% | +12.84% | 20.66B | ||
| Average | +0.56% | +1.33% | +15.96% | +10.75% | 59.65B | |
| Weighted average by Cap. | +0.41% | +1.21% | +9.66% | -3.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3,700B 2.42B 2.11B 1.94B 1.81B 3.43B 230B 3.49B 23.32B 9.06B 113B 9.07B 8.88B 390B | 3,917B 2.56B 2.24B 2.06B 1.92B 3.64B 244B 3.69B 24.68B 9.6B 120B 9.61B 9.4B 413B |
| Net income | 479B 313M 274M 251M 234M 444M 29.79B 451M 3.02B 1.17B 14.64B 1.17B 1.15B 50.46B | 522B 341M 298M 274M 256M 485M 32.49B 492M 3.29B 1.28B 15.97B 1.28B 1.25B 55.03B |
| Net Debt | -1,464B -956M -836M -768M -716M -1.36B -91.07B -1.38B -9.22B -3.59B -44.76B -3.59B -3.51B -154B | -1,757B -1.15B -1B -922M -859M -1.63B -109B -1.65B -11.07B -4.3B -53.71B -4.31B -4.22B -185B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | ₩136,300.00 | -1.94% | 107,104 |
| 02/07/26 | ₩139,000.00 | +1.68% | 193,800 |
| 01/07/26 | ₩136,700.00 | +3.64% | 77,243 |
| 30/06/26 | ₩131,900.00 | -4.35% | 126,462 |
| 29/06/26 | ₩137,900.00 | +9.10% | 182,220 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A271560 Stock
Select your edition
All financial news and data tailored to specific country editions
















